NSW Cancer Lifestyle and Evaluation of Risk Study (CLEAR Study)
A multi-centre case-control surveillance study in the NSW population to provide ongoing data on the relative importance of known or emerging exposures and their relationships to leading or emerging cancer types.
Cancer Council NSW
10,000 participants
Jan 1, 2007
Observational
Conditions
Summary
The NSW Cancer, Lifestyle, and the Evaluation of Risk (CLEAR) Study is a multi-centre case-control surveillance study in the NSW population. The objectives of the study are: 1. To provide ongoing data on the relative importance of known or emerging exposures and their relationships to leading or emerging cancer types. 2. To investigate in the short term once sample sizes permit, the effects of migration, ethnicity, physical activity, alcohol consumption, smoking, reproductive history, occupation, screening behaviour and certain dietary patterns on the risk of developing cancer of the colon and rectum, prostate, breast and lung, cutaneous melanoma and non-Hodgkin lymphoma. 3. To investigate in the longer term, once sample sizes permit, the effects of these factors on rarer cancer types, such as hepatoma, thyroid, ovarian and pancreatic cancers. 4. To develop a recruitment infrastructure and biological repository of sufficient size to enable the testing of new hypotheses on gene and environment factors, and in some situations, gene-environment interactions, on the risk of cancers affecting the Australian population.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Questionnaire (survey) and a blood sample (optional). Survey questions relate to lifestyle and risk factors a person may have been exposed to during their lifetime. Data from questionnaires of cancer patients and cancer free controls will be compared. Blood samples will be analysed in the future in a quest to identify known or new biomarkers for disease. Data from blood analyses fror cancer patients and cancer free controls will be compared. This is a one-off intervention: completion of one questionnaire and donation of one blood sample. There is no follow up for the participant.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000678998